EVALUATION OF DRUG-DRUG INTERACTIONS TO INFORM DRUG USE

被引：0
|
作者：
Zhang, Lei [1 ]
机构：
[1] US FDA, Silver Spring, MD USA
来源：
DRUG METABOLISM AND PHARMACOKINETICS | 2018年 / 33卷 / 01期
关键词：
PREDICTION;
D O I：
10.1016/j.dmpk.2017.11.020
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SC4.1
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [21] Risk Assessment of Mechanism-Based Inactivation in Drug-Drug Interactions
    Fujioka, Yasushi
    Kunze, Kent L.
    Isoherranen, Nina
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1653 - 1657
  • [22] Risk assessment of drug-drug interactions using hepatocytes suspended in serum during the drug discovery process
    Kosugi, Yohei
    Hirabayashi, Hideki
    Igari, Tomoko
    Fujioka, Yasushi
    Okuda, Teruaki
    Moriwaki, Toshiya
    XENOBIOTICA, 2014, 44 (04) : 336 - 344
  • [23] Predict multi-type drug-drug interactions in cold start scenario
    Liu, Zun
    Wang, Xing-Nan
    Yu, Hui
    Shi, Jian-Yu
    Dong, Wen-Min
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [24] Database analyses for the prediction of in vivo drug-drug interactions from in vitro data
    Ito, K
    Brown, HS
    Houston, JB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (04) : 473 - 486
  • [25] Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil
    Chanteux, Hugues
    MacPherson, Merran
    Kramer, Hester
    Otoul, Christian
    Okagaki, Takuya
    Rospo, Chiara
    De Bruyn, Steven
    Watling, Mark
    Bani, Massimo
    Sciberras, David
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (08) : 841 - 855
  • [26] Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug-Drug Interactions
    Cilliers, Cornelius
    Howgate, Eleanor
    Jones, Hannah M.
    Rahbaek, Lisa
    Tran, Jonathan Q.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (03) : 732 - 741
  • [27] Bioavailability Considerations in Evaluating Drug-Drug Interactions Using the Population Pharmacokinetic Approach
    Duan, John Z.
    Jackson, Andre J.
    Zhao, Ping
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (07) : 1087 - 1100
  • [28] Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug-Drug and Drug-Disease Interactions of Apatinib
    Liu, Hongrui
    Yu, Yiqun
    Guo, Nan
    Wang, Xiaojuan
    Han, Bing
    Xiang, Xiaoqiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [29] Evaluation of cytochrome P450-mediated drug-drug interactions based on the strategies recommended by regulatory authorities
    Kosugi, Yohei
    Hirabayashi, Hideki
    Igari, Tomoko
    Fujioka, Yasushi
    Hara, Yoko
    Okuda, Teruaki
    Moriwaki, Toshiya
    XENOBIOTICA, 2012, 42 (02) : 127 - 138
  • [30] Architecture of the drug-drug interaction network
    Hu, T. -M.
    Hayton, W. L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (02) : 135 - 143
12345